[{"notes_id":"1_1574","category":"8","subcategory":"0","title":"Amiodarone and the thyroid gland","body":"Around 1 in 6 patients taking amiodarone develop thyroid dysfunction<br \/><br \/><h5 class='notes-heading'>Amiodarone-induced hypothyroidism<\/h5><br \/>The pathophysiology of amiodarone-induced hypothyroidism (AIH) is thought to be due to the high iodine content of amiodarone causing a Wolff-Chaikoff effect*<br \/><br \/>Amiodarone may be continued if this is desirable<br \/><br \/><h5 class='notes-heading'>Amiodarone-induced thyrotoxicosis<\/h5><br \/>Amiodarone-induced thyrotoxicosis (AIT) may be divided into two types:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><\/th><th><b>AIT type 1<\/b><\/th><th><b>AIT type 2<\/b><\/th><\/tr><\/thead><tbody><tr><td>Pathophysiology<\/td><td><span class=\"concept\" data-cid=\"12073\">Excess iodine-induced thyroid hormone synthesis<\/span><\/td><td>Amiodarone-related destructive thyroiditis<\/td><\/tr><tr><td>Goitre<\/td><td>Present<\/td><td>Absent<\/td><\/tr><tr><td>Management<\/td><td>Carbimazole or potassium perchlorate<\/td><td>Corticosteroids<\/td><\/tr><\/tbody><\/table><\/div><br \/>Unlike in AIH, amiodarone should be stopped if possible in patients who develop AIT<br \/><br \/>*an autoregulatory phenomenon where thyroxine formation is inhibited due to high levels of circulating iodide","notes_hash":"1c7c980953b8eb68f82289613248a026","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>NCBI<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1464\" data-linkid=\"1464\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1464\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1464\" data-linkid=\"1464\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1464\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4212191\/\">Amiodarone-induced thyrotoxicosis: type 1 or type 2?<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":[],"category_name":"Pharmacology and therapeutics","subcategory_name":"","comment_count":3},"",[]]